Vitrafy Partners with Versiti for Platelet Cryopreservation
Key points
- Vitrafy partners with Versiti Blood Health for platelet cryopreservation
- Third U.S. partnership for Vitrafy, focused on platelets
- Aims to address platelet shortages in hospitals
Full summary
Vitrafy Life Sciences Ltd has announced a partnership with Versiti Blood Health, a U.S. non-profit blood network, to advance the development of Vitrafy's cryopreservation ecosystem for platelets. This partnership follows Vitrafy's in-vitro platelet study with the United States Army Institute of Surgical Research and supports verification and validation activities for Vitrafy's planned U.S. medical device listing. Vitrafy and Versiti will contribute resources to develop Vitrafy's cryopreservation ecosystem for no-wash platelet cryopreservation within Versiti's platelet workflows. Vitrafy will place two cryopreservation freezing units at Versiti's facility in Milwaukee, Wisconsin, without generating revenue.
Summary generated by a large language model. Please interpret with care.